| Literature DB >> 21249417 |
Eugenia Rota1, Andrea Evangelista, Giovannino Ciccone, Luca Ferrero, Alessandro Ugolini, Chantal Milani, Manuela Ceccarelli, Claudia Galassi, Franco Mongini.
Abstract
The objective of this study is to evaluate the effectiveness of an educational and physical program in reducing behavioral or somatic symptoms along with headache, neck and shoulder pain in a working community. A controlled, non-randomized trial was carried out in a working community and 384 employees were enrolled and divided into a study group (Group 1) and a control group (Group 2). The Group 1 received a physical and educational intervention, consisting of relaxation and posture exercises and the use of visual feedback. After 6 months, the intervention was administered to the Group 2. Both groups were then followed for an additional 6 months until the end of the trial. The presence of accompanying symptoms was investigated with a semi-structured interview using a checklist of 20 items, along with headache, neck, and shoulder pain parameters and the prevalence of generalized anxiety disorder and depression, in three clinical examinations at baseline, after 6 months and after 12 months. For each symptom, as well as the presence of any type of symptom, the differences between groups in the prevalence at the clinical examinations following the baseline were evaluated by applying logistic models. After 6 months, the probability of the presence of any type of symptom was significantly lower in the Group 1 (OR 0.69, 95% CI 0.56-0.85) with respect to the Group 2. After 12 months, the pooled estimation did not show any significant difference of symptom prevalence between groups (OR 0.80, 95% CI 0.64-1.00). In conclusion, this is the first longitudinal study relative to accompanying symptoms. Its results suggest the effectiveness of this cognitive program in reducing the burden of physical and psychiatric complaints in a large, working population.Entities:
Mesh:
Year: 2011 PMID: 21249417 PMCID: PMC3094669 DOI: 10.1007/s10194-011-0291-y
Source DB: PubMed Journal: J Headache Pain ISSN: 1129-2369 Impact factor: 7.277
Fig. 1Flow chart
Characteristics of study population at the baseline (clinical examination 1)
| Group 1 ( | Group 2 ( |
| |
|---|---|---|---|
| Age, median (IQR) | 48 (43–53) | 44 (36–50) | <0.001 |
| Female, | 150 (78.1%) | 158 (82.3%) | 0.305 |
| Migraine with or without aura (M), without TTH, | 53 (27.6%) | 58 (30.2%) | 0.574 |
| Tension-type headache (TTH), without M, | 33 (17.2%) | 52 (27.1%) | 0.020 |
| Migraine and TTH, | 51 (26.6%) | 44 (22.9%) | 0.408 |
| Myogenous neck and shoulder pain (MP), | 123 (64.1%) | 146 (76.0%) | 0.010 |
Symptom frequencies (%) by group at each clinical examination
| Group 1 Examination | Group 2 Examination | |||||
|---|---|---|---|---|---|---|
| 1 ( | 2 ( | 3 ( | 1 ( | 2 ( | 3 ( | |
| Symptom | ||||||
| Colitis | 21.4 | 21.9 | 21.0 | 27.6 | 21.7 | 23.8 |
| Gastritis | 19.8 | 20.1 | 19.7 | 18.2 | 22.3 | 18.3 |
| Swallowing diff. | 7.8 | 7.7 | 5.7 | 5.7 | 6.9 | 4.9 |
| Digestion diff. | 21.9 | 23.7 | 21.0 | 18.8 | 24.6 | 23.2 |
| Phobias | 18.2 | 9.5 | 10.2 | 15.6 | 14.3 | 9.8 |
| Sleep disorders | 46.4 | 37.3 | 39.5 | 39.1 | 41.1 | 41.5 |
| Palpitations | 24.5 | 19.5 | 15.9 | 25.0 | 29.7 | 28.0 |
| Panic attacks | 10.9 | 6.5 | 2.5 | 6.8 | 4.0 | 4.9 |
| Fainting | 1.6 | 1.2 | 1.3 | 5.7 | 3.4 | 0.0 |
| Dizzines | 20.3 | 21.9 | 16.6 | 18.2 | 18.9 | 18.9 |
| Tinnitus | 15.1 | 13.6 | 10.2 | 9.4 | 8.0 | 9.1 |
| Weariness | 35.9 | 39.6 | 52.2 | 42.7 | 45.1 | 53.0 |
| Cramps | 32.3 | 30.2 | 29.3 | 26.0 | 33.1 | 26.8 |
| Paresthesias | 33.3 | 26.6 | 28.7 | 28.1 | 32.6 | 29.3 |
| Back pain | 50.5 | 44.4 | 39.5 | 50.0 | 49.1 | 43.9 |
| Urinary disorders | 9.4 | 7.1 | 5.7 | 8.9 | 11.4 | 5.5 |
| Circulation disorders | 21.9 | 11.8 | 17.2 | 25.0 | 18.3 | 25.6 |
| Anorexia/bulimia | 19.3 | 16.0 | 17.2 | 11.5 | 11.4 | 15.9 |
| Oral parafun. | 27.6 | 39.6 | 33.1 | 32.8 | 39.4 | 33.5 |
| Nail/hair fragil. | 26.0 | 21.3 | 22.9 | 30.2 | 33.1 | 25.6 |
| GAD | 25.5 | 21.3 | 23.6 | 25.0 | 28.0 | 18.3 |
| Depression | 15.1 | 11.2 | 7.7 | 14.1 | 13.8 | 9.2 |
Examination 1 = baseline; examination 2 = after 6 months, when only Group 1 received the intervention; examination 3 = at the end of the study, when Group 2 also received the intervention
Fig. 2Differences between groups on the prevalence of accompanying symptoms (logistic regression models). The estimations are not plotted for fainting due to very large standard errors